Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Neostigmine Methylsulfate Injection

Approval Number

国药准字H20258016

Company广州瑞尔医药科技有限公司

Registration Date

February 18, 2025

Previous Approval Numbers

国药准字H20243425

Drug Information

Generic Name

甲硫酸新斯的明注射液

Dosage Form

注射剂

Strength

2ml:1mg

Drug Type

化学药品

Registration Date

February 18, 2025

Company Information

Applicant Company

Company Name广州瑞尔医药科技有限公司

Company Address

广州高新技术产业开发区科学城揽月路80号科技创新基地D区第6层601-603单元

Manufacturing Company

Company Name河北凯威制药有限责任公司

Company Address

河北省张家口市宣化县沙岭子镇（东山产业集聚区）

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

甲硫酸新斯的明注射液 - NMPA 批准文号 | MedPath